Estados Unidos · Plataformas y datos · Finviz

DSS, Inc. Announces SEC Declaration of Effectiveness of Form F-4 Registration Statement, Marking Major Milestone Toward Closing of Proposed Business Combination

Publicado por Finviz · Estados Unidos hace 10 h

Special meeting of Impact Biomedical stockholders to approve the proposed Business Combination scheduled for November 13, 2026, at 10:00 a.m. Eastern Standard Time Upon closing,…

Leer el artículo completo en Finviz Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (finviz.com)

DSS, Inc. Announces SEC Declaration of Effectiveness of Form F-4 Registration Statement, Marking Major Milestone Toward Closing of Proposed Business Combination

También te puede interesar

Abbott Laboratories (NYSE:ABT) Stock Sale Revealed by Rep. Thomas H. Kean, Jr.

Michael Burry adds to BYD, SFM, JD, sees up to 140% potential in Fiserv

Blackstone president calls for more equity to fund AI buildout as debt risks mount

Vertex (VRTX) Q3 2026 Earnings Call Transcript

Why is Virgin Australia stock surging today?

Here’s why Palantir’s stock is down despite a ‘bombastic’ quarter

DSS, Inc. Announces SEC Declaration of Effectiveness of Form F-4 Registration Statement, Marking Major Milestone Toward Closing of Proposed Business Combination

Compartir

También te puede interesar

Abbott Laboratories (NYSE:ABT) Stock Sale Revealed by Rep. Thomas H. Kean, Jr.

Michael Burry adds to BYD, SFM, JD, sees up to 140% potential in Fiserv

Blackstone president calls for more equity to fund AI buildout as debt risks mount

Vertex (VRTX) Q3 2026 Earnings Call Transcript

Why is Virgin Australia stock surging today?

Here’s why Palantir’s stock is down despite a ‘bombastic’ quarter